Cidara Provides Corporate Update and Reports First Quarter 2017 Financial Results
10 mai 2017 17h06 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, May 10, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Therapeutics Reports Unfavorable Results of Phase 2 RADIANT Trial of CD101 Topical in VVC
21 févr. 2017 07h30 HE
|
Cidara Therapeutics, Inc.
Further Development of CD101 Topical for VVC to be discontinued CD101 IV development program in candidemia and invasive candidiasis (including Phase 2 STRIVE trial) continuing and remains on track ...
Cidara Provides Corporate Update and Reports Third Quarter 2016 Financial Results
10 nov. 2016 16h10 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Therapeutics Announces Pricing of Public Offering of Common Stock
07 oct. 2016 09h00 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 07, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing...
Cidara Reports Second Quarter 2016 Financial Results and Provides Corporate Update
11 août 2016 16h12 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics to Present at the Jefferies 2016 Healthcare Conference
02 juin 2016 08h00 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, June 02, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics to Present at the Needham & Company 15th Annual Healthcare Conference
05 avr. 2016 07h30 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, April 05, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update
18 mars 2016 07h30 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, March 18, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics Announces Participation in Leerink Partners 5th Annual Global Healthcare Conference
03 févr. 2016 07h30 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics Set to Join Russell Indexes
23 juin 2015 16h10 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, June 23, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections,...